Skip to content
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•20 filings

COCH

Envoy Medical, Inc.

No net buying or selling imbalance over the last 3 months

No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 6 CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

$0.00

0 buyers · 0 sellers

12-month purchases

$8,173,460

6 distinct insiders

12-month sales

$0.00

0 distinct insiders

Highlighted alerts

18

0 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

6 executive purchases found

Get COCH insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

COCH overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

45
Raw transactions
Everything returned by the filing
18
Voluntary view
P/S trades after deterministic checks
20
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
Code
A
Shares
250,000
Price
$0.00
Footnotes
5

Options to purchase 3,750 shares vest on 2/5/2027, and 11,250 shares vest pro rata on the 5th of each month thereafter for 36 consecutive months. Options to purchase 62,500 shares vest on 8/24/2027, and 187,500 shares vest pro rata on the 24th of each month thereafter for 36 consecutive months. Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants. The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device. The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device.

Raspberry interpretation
Informational — no alert

Reason: administrative_code.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

18 transactions

TAYLOR GLEN A

10% owner

PurchaseAlert
Shares
18,750,000
Price
$0.40
Value
$7,500,000
Open SEC filing

TAYLOR GLEN A

10% owner

PurchaseAlert
Shares
18,750,000
Price
$0.00
Value
$0.00
Open SEC filing

TAYLOR GLEN A

10% owner

PurchaseAlert
Shares
11,250,000
Price
$0.00
Value
$0.00
Open SEC filing

Patel Mona Chetan

Director

PurchaseAlert
Shares
312,500
Price
$0.40
Value
$125,000
Open SEC filing

Patel Mona Chetan

Director

PurchaseAlert
Shares
312,500
Price
$0.00
Value
$0.00
Open SEC filing

Patel Mona Chetan

Director

PurchaseAlert
Shares
187,500
Price
$0.00
Value
$0.00
Open SEC filing

Potashnick Robert

Interim CFO

PurchaseAlert
Shares
212,500
Price
$0.40
Value
$85,000
Open SEC filing

Potashnick Robert

Interim CFO

PurchaseAlert
Shares
212,500
Price
$0.00
Value
$0.00
Open SEC filing

Potashnick Robert

Interim CFO

PurchaseAlert
Shares
127,500
Price
$0.00
Value
$0.00
Open SEC filing

Kantor Susan

Director

PurchaseAlert
Shares
96,150
Price
$0.40
Value
$38,460
Open SEC filing

Kantor Susan

Director

PurchaseAlert
Shares
96,150
Price
$0.00
Value
$0.00
Open SEC filing

Kantor Susan

Director

PurchaseAlert
Shares
57,690
Price
$0.00
Value
$0.00
Open SEC filing

BRYNELSEN CHARLES

Director

PurchaseAlert
Shares
1,000,000
Price
$0.40
Value
$400,000
Open SEC filing

BRYNELSEN CHARLES

Director

PurchaseAlert
Shares
1,000,000
Price
$0.00
Value
$0.00
Open SEC filing

BRYNELSEN CHARLES

Director

PurchaseAlert
Shares
600,000
Price
$0.00
Value
$0.00
Open SEC filing

Lucas Brent T.

Chief Executive Officer

PurchaseAlert
Shares
62,500
Price
$0.40
Value
$25,000
Open SEC filing

Lucas Brent T.

Chief Executive Officer

PurchaseAlert
Shares
62,500
Price
$0.00
Value
$0.00
Open SEC filing

Lucas Brent T.

Chief Executive Officer

PurchaseAlert
Shares
37,500
Price
$0.00
Value
$0.00
Open SEC filing

“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.